Report- Cilostazol-Market-Report-2017 | Page 5
10.6.2.1 Product A
10.6.2.2 Product B
10.6.3 Sandoz Cilostazol Sales, Revenue, Price and Gross Margin (2012-2017)
10.6.4 Main Business/Business Overview
10.7 Hikma Pharmaceuticals
10.7.1 Company Basic Information, Manufacturing Base and Competitors
10.7.2 Cilostazol Product Type, Application and Specification
10.7.2.1 Product A
10.7.2.2 Product B
10.7.3 Hikma Pharmaceuticals Cilostazol Sales, Revenue, Price and Gross Margin (2012-2017)
10.7.4 Main Business/Business Overview
10.8 GSK
10.8.1 Company Basic Information, Manufacturing Base and Competitors
10.8.2 Cilostazol Product Type, Application and Specification
10.8.2.1 Product A
10.8.2.2 Product B
10.8.3 GSK Cilostazol Sales, Revenue, Price and Gross Margin (2012-2017)
10.8.4 Main Business/Business Overview
10.9 Mayne Pharma Inc
10.9.1 Company Basic Information, Manufacturing Base and Competitors
10.9.2 Cilostazol Product Type, Application and Specification
10.9.2.1 Product A
10.9.2.2 Product B
10.9.3 Mayne Pharma Inc Cilostazol Sales, Revenue, Price and Gross Margin (2012-2017)
10.9.4 Main Business/Business Overview
10.10 Bedford Laboratories
10.10.1 Company Basic Information, Manufacturing Base and Competitors
10.10.2 Cilostazol Product Type, Application and Specification
10.10.2.1 Product A
10.10.2.2 Product B
10.10.3 Bedford Laboratories Cilostazol Sales, Revenue, Price and Gross Margin (2012-2017)
10.10.4 Main Business/Business Overview
10.11 Abbott
10.12 Takeda
10.13 Zhejiang Otsuka Pharmaceutical
10.14 Zhejiang Weikang Pharmaceutical
10.15 Chongqing Pharscin pharmaceutical
10.16 Chengdu Leer Pharmaceutical
10.17 Yantai Yisheng Pharmaceutical
10.18 Korea Otsuka Pharmaceutical
10.19 Cadila Pharmaceuticals Limited
10.20 Otsuka American Pharmaceuticals
11 Cilostazol Manufacturing Cost Analysis
11.1 Cilostazol Key Raw Materials Analysis
11.1.1 Key Raw Materials
11.1.2 Price Trend of Key Raw Materials
11.1.3 Key Suppliers of Raw Materials
11.1.4 Market Concentration Rate of Raw Materials
11.2 Proportion of Manufacturing Cost Structure